Delivery Order SPE2DR25D1109-SPE2DR26FFK2U
- Not listed
- The Defense Logistics Agency awarded a $17,581.86 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Taltz 80 mg/ml auto-injector medication. This firm fixed-price contract, which is not set-aside, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,408.43 for TALTZ 80 MG/ML AutoInjector on October 29, 2025, with an ultimate completion date of October 30, 2025. This firm fixed price, competitively awarded delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion pharmaceutical prime vendor agreement running through December 2026. The delivery...
- The Defense Logistics Agency awarded a $1,749.70 delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of TALTZ 80 mg/ml autoinjector medication. This is a firm fixed price, competitively awarded contract with performance completion scheduled for December 12, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $30,520.46 to supply Taltz 80 mg/ml autoinjectors. The award was made on November 28, 2025, with an ultimate completion date of December 1, 2025, under a firm fixed-price contract type with no set-aside designation. The contract will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Taltz 80 mg/ml autoinjector with a ceiling value of $7,605.54 under a firm fixed-price contract type. The award was made on November 14, 2025, with an ultimate completion date of November 17, 2025. This is a non-set-aside competitive award, and performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under...
- The Defense Logistics Agency awarded a $11,017.75 delivery order to AmerisourceBergen Drug Corp for the supply of Taltz 80 mg/ml autoinjector on December 11, 2025, with completion scheduled for December 12, 2025. This is a firm fixed-price, non-set-aside contract executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999 and extends through December 2026. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml autoinjector medication, with a firm fixed price ceiling value of $8,122.52. The award, issued on December 31, 2025, is scheduled for completion by January 2, 2026, and represents a non-competitive child delivery order under the company's existing contract vehicle. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Taltz 80 mg/ml autoinjectors with a ceiling value of $4,197.10. This is a firm fixed-price delivery order with an ultimate completion date of July 22, 2025, reflecting a short fulfillment timeline for this pharmaceutical product. The contract utilizes no set-aside designation, indicating it was competitively awarded. AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $80,176.82 delivery order to AmerisourceBergen Drug Corp for Taltz 80 mg/ml auto-injectors (2-pack) with a completion date of November 26, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. The delivery...
- The Defense Logistics Agency (DLA) awarded a $4,188.00 delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for TALTZ 80 mg/ml autoinjectors, with completion scheduled for December 2, 2025. This non-competitive delivery order utilizes a firm fixed price structure and represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, where the...
- SPE2DR25D1109Indefinite Delivery Contract
- SPE2DR25D1109-SPE2DR26FFK2UDelivery Order
The Defense Logistics Agency awarded a $1,749.70 delivery order to AmerisourceBergen Drug Corp (parent company Cencora, Inc.) on January 7, 2026, for the supply of Taltz 80 mg/ml autoinjector medication. This firm fixed-price delivery order, with a completion date of January 8, 2026, represents a single task order under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2026. The contract was competitively awarded with no set-aside designation, demonstrating the contractor's capability to meet federal procurement requirements in open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order supports the Defense Logistics Agency's Medical Supply Chain, which provides pharmaceutical products and medical supplies to military healthcare systems and veterans' programs. Taltz, a biologic medication commonly used for autoimmune conditions, is one of many specialty pharmaceutical products that AmerisourceBergen supplies through its federal contract vehicles. The award reflects the contractor's ongoing role as a critical pharmaceutical distributor for Department of Defense medical procurement needs, with the company maintaining a robust portfolio of brand-name and generic medications, vaccines, and specialized medical devices across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 1/6/26 |